Le Lézard
Classified in: Health, Covid-19 virus
Subject: TDS

Messer Highlights Pandemic-Tested National Medical Gas Delivery Network at ASHE 2020


BRIDGEWATER, N.J., Sept. 28, 2020 /PRNewswire/ -- Messer, a global leader in medical and industrial gases and technology, has maintained continuity of supply to NYC hospitals during the COVID-19 outbreak by drawing on its national network of Air Separation Units (ASUs), delivery fleet, local service technicians, bulk emergency supply plans, and technical expertise to develop rapid response solutions. Messer will showcase its significant supply capability and its unique Design, Build, Provide service for hospital gas supply systems at the virtual ASHE 2020 Annual Conference Oct. 5-7.

"Messer remains laser-focused on offering reliable bulk oxygen supply and emergency response systems," said Chris Ebeling, Executive Vice President, Sales & Marketing, U.S. Bulk at Messer. "We are focused solely on bulk gases, and our experienced team met hospitals' supply challenges even as oxygen demand surged at rates exceeding 5 times baseline usage during the New York City outbreak. We increased oxygen production and maintained continuity of supply by reallocating distribution resources."

In addition, Messer deployed both engineers and technicians to customer locations, drawing on their deep expertise to implement creative technical solutions to ensure that hospitals maintained their oxygen supply, despite the increased demand. Additionally, Messer's Hospital Services team helped hospitals upgrade medical bulk equipment and increase capacity for future needs.

As the outbreak in New York subsided, Messer took its emergency learnings nationwide to assist hospital engineers. Providing guidance on bulk medical equipment capacities allowed the hospitals to plan for virus-related increases in oxygen demand.

Hospital Services ? Design, Build, Provide

Messer will also highlight its key Hospital Services capabilities offering, which delivers turnkey medical gas solutions from conception to commissioning. Working with the medical facility, Messer's Hospital Services Engineering team will manage project "Design" and engineering, the "Build" of all the required construction scopes, and the "Provision" of the medical gas equipment. This is all completed with continuity of supply, service and maintenance.

To learn more about Messer's healthcare operations or the Design, Build, Provide offering, visit: https://www.messer-us.com/healthcare.

About Messer
Messer is the largest privately held industrial gas business in the world, and a leading industrial and medical gas company in North and South America. Messer offers over 120 years of expertise in industrial, medical, specialty, and electronic gases and safely delivers quality gases, related services and technology via an extensive production and distribution network. Messer Americas is part of Messer Group, representing a USD 3.5 billion enterprise with presence in the Americas, Europe and Asia. For more information, visit: www.messeramericas.com.

SOURCE Messer Americas


These press releases may also interest you

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: